nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1B1—melanoma	0.394	1	CbGaD
Melatonin—CYP1B1—Docetaxel—melanoma	0.0648	0.269	CbGbCtD
Melatonin—CYP1A1—Dacarbazine—melanoma	0.0635	0.264	CbGbCtD
Melatonin—CYP1A2—Carmustine—melanoma	0.0469	0.195	CbGbCtD
Melatonin—CYP1A2—Vemurafenib—melanoma	0.037	0.154	CbGbCtD
Melatonin—CYP1A2—Dacarbazine—melanoma	0.0284	0.118	CbGbCtD
Melatonin—CALR—skin epidermis—melanoma	0.00555	0.0673	CbGeAlD
Melatonin—MTNR1B—eye—melanoma	0.00378	0.0459	CbGeAlD
Melatonin—MTNR1B—retina—melanoma	0.00375	0.0455	CbGeAlD
Melatonin—ASMT—eye—melanoma	0.00369	0.0447	CbGeAlD
Melatonin—ASMT—retina—melanoma	0.00365	0.0443	CbGeAlD
Melatonin—SLC22A8—optic choroid—melanoma	0.00341	0.0414	CbGeAlD
Melatonin—Rash generalised—Vemurafenib—melanoma	0.00333	0.0398	CcSEcCtD
Melatonin—CALR—neck—melanoma	0.00266	0.0322	CbGeAlD
Melatonin—CALM2—ear—melanoma	0.0023	0.0279	CbGeAlD
Melatonin—CALM1—ear—melanoma	0.00229	0.0278	CbGeAlD
Melatonin—MTNR1B—head—melanoma	0.00215	0.0261	CbGeAlD
Melatonin—ASMT—head—melanoma	0.00209	0.0254	CbGeAlD
Melatonin—CALR—eye—melanoma	0.00198	0.024	CbGeAlD
Melatonin—CALR—retina—melanoma	0.00196	0.0238	CbGeAlD
Melatonin—MPO—endothelium—melanoma	0.00175	0.0212	CbGeAlD
Melatonin—CALR—skin of body—melanoma	0.00172	0.0209	CbGeAlD
Melatonin—MTNR1A—head—melanoma	0.0017	0.0206	CbGeAlD
Melatonin—MPO—blood vessel—melanoma	0.00161	0.0196	CbGeAlD
Melatonin—CALR—mammalian vulva—melanoma	0.00157	0.019	CbGeAlD
Melatonin—MT3—head—melanoma	0.00142	0.0173	CbGeAlD
Melatonin—IDO1—lymph node—melanoma	0.00134	0.0163	CbGeAlD
Melatonin—Nail disorder—Bleomycin—melanoma	0.00132	0.0158	CcSEcCtD
Melatonin—CYP1B1—hair follicle—melanoma	0.00131	0.0159	CbGeAlD
Melatonin—CYP1A1—skin epidermis—melanoma	0.0013	0.0158	CbGeAlD
Melatonin—CALM2—endothelium—melanoma	0.00123	0.015	CbGeAlD
Melatonin—CALM1—endothelium—melanoma	0.00123	0.0149	CbGeAlD
Melatonin—Visual acuity reduced—Temozolomide—melanoma	0.00121	0.0145	CcSEcCtD
Melatonin—CALM2—hair follicle—melanoma	0.00121	0.0147	CbGeAlD
Melatonin—ESR1—blood vessel—melanoma	0.00115	0.0139	CbGeAlD
Melatonin—CALM2—blood vessel—melanoma	0.00114	0.0138	CbGeAlD
Melatonin—CALM1—blood vessel—melanoma	0.00113	0.0137	CbGeAlD
Melatonin—Rash generalised—Docetaxel—melanoma	0.00113	0.0135	CcSEcCtD
Melatonin—CALR—head—melanoma	0.00112	0.0136	CbGeAlD
Melatonin—Arthritis—Vemurafenib—melanoma	0.00106	0.0126	CcSEcCtD
Melatonin—Prurigo—Docetaxel—melanoma	0.00104	0.0125	CcSEcCtD
Melatonin—Pain in extremity—Vemurafenib—melanoma	0.00103	0.0123	CcSEcCtD
Melatonin—MT3—lymph node—melanoma	0.000996	0.0121	CbGeAlD
Melatonin—Aggression—Bleomycin—melanoma	0.000975	0.0117	CcSEcCtD
Melatonin—Herpes zoster—Temozolomide—melanoma	0.00096	0.0115	CcSEcCtD
Melatonin—Dry skin—Vemurafenib—melanoma	0.000941	0.0113	CcSEcCtD
Melatonin—Memory impairment—Temozolomide—melanoma	0.000921	0.011	CcSEcCtD
Melatonin—NQO2—mammalian vulva—melanoma	0.000885	0.0107	CbGeAlD
Melatonin—Hypocalcaemia—Dactinomycin—melanoma	0.000873	0.0104	CcSEcCtD
Melatonin—Disturbance in attention—Temozolomide—melanoma	0.000834	0.00998	CcSEcCtD
Melatonin—ESR1—neck—melanoma	0.000819	0.00994	CbGeAlD
Melatonin—CALM2—neck—melanoma	0.000814	0.00988	CbGeAlD
Melatonin—CALM1—neck—melanoma	0.00081	0.00983	CbGeAlD
Melatonin—Hyperbilirubinaemia—Temozolomide—melanoma	0.000795	0.00951	CcSEcCtD
Melatonin—Infestation NOS—Vemurafenib—melanoma	0.000791	0.00947	CcSEcCtD
Melatonin—Infestation—Vemurafenib—melanoma	0.000791	0.00947	CcSEcCtD
Melatonin—CALR—lymph node—melanoma	0.000786	0.00953	CbGeAlD
Melatonin—CALM3—eye—melanoma	0.000771	0.00936	CbGeAlD
Melatonin—CALM3—retina—melanoma	0.000764	0.00927	CbGeAlD
Melatonin—Hepatic enzyme increased—Temozolomide—melanoma	0.000764	0.00915	CcSEcCtD
Melatonin—Neck pain—Carmustine—melanoma	0.000757	0.00906	CcSEcCtD
Melatonin—MPO—skin of body—melanoma	0.000747	0.00906	CbGeAlD
Melatonin—Nail disorder—Docetaxel—melanoma	0.000741	0.00887	CcSEcCtD
Melatonin—Mouth ulceration—Dactinomycin—melanoma	0.000722	0.00865	CcSEcCtD
Melatonin—Connective tissue disorder—Vemurafenib—melanoma	0.000698	0.00835	CcSEcCtD
Melatonin—Disorientation—Bleomycin—melanoma	0.000695	0.00832	CcSEcCtD
Melatonin—SLC22A8—eye—melanoma	0.000686	0.00832	CbGeAlD
Melatonin—Eye disorder—Vemurafenib—melanoma	0.000663	0.00794	CcSEcCtD
Melatonin—Cardiac disorder—Vemurafenib—melanoma	0.000659	0.00789	CcSEcCtD
Melatonin—CYP1B1—eye—melanoma	0.000655	0.00795	CbGeAlD
Melatonin—Angiopathy—Vemurafenib—melanoma	0.000644	0.00771	CcSEcCtD
Melatonin—Arthritis—Bleomycin—melanoma	0.00064	0.00766	CcSEcCtD
Melatonin—NQO2—head—melanoma	0.000633	0.00768	CbGeAlD
Melatonin—Malnutrition—Vemurafenib—melanoma	0.000618	0.0074	CcSEcCtD
Melatonin—Erythema—Vemurafenib—melanoma	0.000618	0.0074	CcSEcCtD
Melatonin—CALM3—mammalian vulva—melanoma	0.000612	0.00743	CbGeAlD
Melatonin—CALM2—eye—melanoma	0.000606	0.00735	CbGeAlD
Melatonin—CALM1—eye—melanoma	0.000603	0.00732	CbGeAlD
Melatonin—CALM2—retina—melanoma	0.0006	0.00728	CbGeAlD
Melatonin—Back pain—Vemurafenib—melanoma	0.000598	0.00716	CcSEcCtD
Melatonin—CALM1—retina—melanoma	0.000597	0.00725	CbGeAlD
Melatonin—Lethargy—Dactinomycin—melanoma	0.000592	0.00708	CcSEcCtD
Melatonin—CYP1B1—skin of body—melanoma	0.00057	0.00692	CbGeAlD
Melatonin—Hot flush—Temozolomide—melanoma	0.000561	0.00671	CcSEcCtD
Melatonin—Menopausal symptoms—Temozolomide—melanoma	0.000556	0.00665	CcSEcCtD
Melatonin—Thirst—Temozolomide—melanoma	0.000551	0.0066	CcSEcCtD
Melatonin—Hyponatraemia—Carmustine—melanoma	0.000545	0.00652	CcSEcCtD
Melatonin—Liver function test abnormal—Dactinomycin—melanoma	0.000535	0.00641	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Docetaxel—melanoma	0.000528	0.00633	CcSEcCtD
Melatonin—CALM2—skin of body—melanoma	0.000527	0.00639	CbGeAlD
Melatonin—Arthralgia—Vemurafenib—melanoma	0.000526	0.0063	CcSEcCtD
Melatonin—CALM1—skin of body—melanoma	0.000525	0.00636	CbGeAlD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000523	0.00626	CcSEcCtD
Melatonin—Lacrimation increased—Docetaxel—melanoma	0.000521	0.00624	CcSEcCtD
Melatonin—Affect lability—Temozolomide—melanoma	0.000516	0.00618	CcSEcCtD
Melatonin—Infection—Vemurafenib—melanoma	0.000501	0.006	CcSEcCtD
Melatonin—Liver function test abnormal—Carmustine—melanoma	0.000501	0.006	CcSEcCtD
Melatonin—Mood swings—Temozolomide—melanoma	0.000497	0.00595	CcSEcCtD
Melatonin—Nervous system disorder—Vemurafenib—melanoma	0.000495	0.00592	CcSEcCtD
Melatonin—Skin disorder—Vemurafenib—melanoma	0.00049	0.00587	CcSEcCtD
Melatonin—MPO—head—melanoma	0.000487	0.00591	CbGeAlD
Melatonin—Dry skin—Temozolomide—melanoma	0.000481	0.00576	CcSEcCtD
Melatonin—CALM2—mammalian vulva—melanoma	0.000481	0.00583	CbGeAlD
Melatonin—CALM1—mammalian vulva—melanoma	0.000478	0.0058	CbGeAlD
Melatonin—Breast disorder—Temozolomide—melanoma	0.000474	0.00567	CcSEcCtD
Melatonin—Stomatitis—Bleomycin—melanoma	0.000467	0.00559	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00046	0.0055	CcSEcCtD
Melatonin—Haematuria—Bleomycin—melanoma	0.000457	0.00547	CcSEcCtD
Melatonin—NQO2—lymph node—melanoma	0.000443	0.00538	CbGeAlD
Melatonin—Stomatitis—Dactinomycin—melanoma	0.000436	0.00521	CcSEcCtD
Melatonin—Gastrointestinal disorder—Vemurafenib—melanoma	0.000435	0.00521	CcSEcCtD
Melatonin—Fatigue—Vemurafenib—melanoma	0.000435	0.00521	CcSEcCtD
Melatonin—Weight increased—Temozolomide—melanoma	0.000413	0.00494	CcSEcCtD
Melatonin—Stomatitis—Carmustine—melanoma	0.000408	0.00488	CcSEcCtD
Melatonin—Infestation NOS—Temozolomide—melanoma	0.000404	0.00484	CcSEcCtD
Melatonin—Infestation—Temozolomide—melanoma	0.000404	0.00484	CcSEcCtD
Melatonin—CYP1A1—skin of body—melanoma	0.000403	0.00489	CbGeAlD
Melatonin—CYP19A1—head—melanoma	0.000398	0.00483	CbGeAlD
Melatonin—Stomatitis—Temozolomide—melanoma	0.000394	0.00472	CcSEcCtD
Melatonin—SLC22A8—head—melanoma	0.000389	0.00473	CbGeAlD
Melatonin—Hepatobiliary disease—Temozolomide—melanoma	0.000382	0.00458	CcSEcCtD
Melatonin—Erythema—Bleomycin—melanoma	0.000374	0.00448	CcSEcCtD
Melatonin—Hot flush—Docetaxel—melanoma	0.000373	0.00446	CcSEcCtD
Melatonin—CYP1B1—head—melanoma	0.000372	0.00451	CbGeAlD
Melatonin—Hypersensitivity—Vemurafenib—melanoma	0.000372	0.00445	CcSEcCtD
Melatonin—Menopausal symptoms—Docetaxel—melanoma	0.00037	0.00443	CcSEcCtD
Melatonin—Connective tissue disorder—Carmustine—melanoma	0.000369	0.00442	CcSEcCtD
Melatonin—CYP1A1—mammalian vulva—melanoma	0.000368	0.00446	CbGeAlD
Melatonin—Asthenia—Vemurafenib—melanoma	0.000362	0.00433	CcSEcCtD
Melatonin—Urinary tract disorder—Temozolomide—melanoma	0.000358	0.00429	CcSEcCtD
Melatonin—Pruritus—Vemurafenib—melanoma	0.000357	0.00427	CcSEcCtD
Melatonin—Connective tissue disorder—Temozolomide—melanoma	0.000357	0.00427	CcSEcCtD
Melatonin—Lethargy—Docetaxel—melanoma	0.000356	0.00426	CcSEcCtD
Melatonin—Urethral disorder—Temozolomide—melanoma	0.000356	0.00426	CcSEcCtD
Melatonin—Eye disorder—Carmustine—melanoma	0.000351	0.0042	CcSEcCtD
Melatonin—Hyponatraemia—Docetaxel—melanoma	0.00035	0.00419	CcSEcCtD
Melatonin—Erythema—Dactinomycin—melanoma	0.000349	0.00418	CcSEcCtD
Melatonin—Pain in extremity—Docetaxel—melanoma	0.000349	0.00418	CcSEcCtD
Melatonin—ESR1—head—melanoma	0.000346	0.0042	CbGeAlD
Melatonin—CALM2—head—melanoma	0.000344	0.00417	CbGeAlD
Melatonin—Migraine—Docetaxel—melanoma	0.000343	0.00411	CcSEcCtD
Melatonin—CALM1—head—melanoma	0.000342	0.00415	CbGeAlD
Melatonin—MPO—lymph node—melanoma	0.000341	0.00414	CbGeAlD
Melatonin—Eye disorder—Temozolomide—melanoma	0.000339	0.00406	CcSEcCtD
Melatonin—Cardiac disorder—Temozolomide—melanoma	0.000337	0.00403	CcSEcCtD
Melatonin—Leukopenia—Bleomycin—melanoma	0.000335	0.00401	CcSEcCtD
Melatonin—Dizziness—Vemurafenib—melanoma	0.000334	0.00399	CcSEcCtD
Melatonin—Angiopathy—Temozolomide—melanoma	0.000329	0.00394	CcSEcCtD
Melatonin—Mental disorder—Carmustine—melanoma	0.000329	0.00394	CcSEcCtD
Melatonin—Immune system disorder—Temozolomide—melanoma	0.000328	0.00392	CcSEcCtD
Melatonin—Malnutrition—Carmustine—melanoma	0.000327	0.00391	CcSEcCtD
Melatonin—Erythema—Carmustine—melanoma	0.000327	0.00391	CcSEcCtD
Melatonin—Liver function test abnormal—Docetaxel—melanoma	0.000322	0.00386	CcSEcCtD
Melatonin—Vomiting—Vemurafenib—melanoma	0.000321	0.00384	CcSEcCtD
Melatonin—Dry skin—Docetaxel—melanoma	0.00032	0.00383	CcSEcCtD
Melatonin—Chest pain—Bleomycin—melanoma	0.000319	0.00382	CcSEcCtD
Melatonin—Abdominal pain upper—Docetaxel—melanoma	0.000319	0.00381	CcSEcCtD
Melatonin—Rash—Vemurafenib—melanoma	0.000318	0.00381	CcSEcCtD
Melatonin—Mental disorder—Temozolomide—melanoma	0.000318	0.00381	CcSEcCtD
Melatonin—Dermatitis—Vemurafenib—melanoma	0.000318	0.0038	CcSEcCtD
Melatonin—Back pain—Carmustine—melanoma	0.000316	0.00378	CcSEcCtD
Melatonin—Headache—Vemurafenib—melanoma	0.000316	0.00378	CcSEcCtD
Melatonin—Malnutrition—Temozolomide—melanoma	0.000316	0.00378	CcSEcCtD
Melatonin—Erythema—Temozolomide—melanoma	0.000316	0.00378	CcSEcCtD
Melatonin—Breast disorder—Docetaxel—melanoma	0.000315	0.00377	CcSEcCtD
Melatonin—Leukopenia—Dactinomycin—melanoma	0.000313	0.00374	CcSEcCtD
Melatonin—Nasopharyngitis—Docetaxel—melanoma	0.000312	0.00373	CcSEcCtD
Melatonin—Vision blurred—Carmustine—melanoma	0.000308	0.00369	CcSEcCtD
Melatonin—CALM3—lymph node—melanoma	0.000307	0.00372	CbGeAlD
Melatonin—Back pain—Temozolomide—melanoma	0.000306	0.00366	CcSEcCtD
Melatonin—Infection—Bleomycin—melanoma	0.000304	0.00363	CcSEcCtD
Melatonin—Agitation—Carmustine—melanoma	0.0003	0.0036	CcSEcCtD
Melatonin—Nausea—Vemurafenib—melanoma	0.0003	0.00359	CcSEcCtD
Melatonin—Thrombocytopenia—Bleomycin—melanoma	0.000299	0.00358	CcSEcCtD
Melatonin—Vision blurred—Temozolomide—melanoma	0.000298	0.00356	CcSEcCtD
Melatonin—Angina pectoris—Docetaxel—melanoma	0.000294	0.00352	CcSEcCtD
Melatonin—Leukopenia—Carmustine—melanoma	0.000293	0.0035	CcSEcCtD
Melatonin—Agitation—Temozolomide—melanoma	0.00029	0.00347	CcSEcCtD
Melatonin—Angioedema—Temozolomide—melanoma	0.000289	0.00346	CcSEcCtD
Melatonin—Vertigo—Temozolomide—melanoma	0.000284	0.0034	CcSEcCtD
Melatonin—Infection—Dactinomycin—melanoma	0.000283	0.00339	CcSEcCtD
Melatonin—Leukopenia—Temozolomide—melanoma	0.000283	0.00338	CcSEcCtD
Melatonin—Hypertension—Carmustine—melanoma	0.000282	0.00338	CcSEcCtD
Melatonin—Palpitations—Temozolomide—melanoma	0.000279	0.00334	CcSEcCtD
Melatonin—Thrombocytopenia—Dactinomycin—melanoma	0.000279	0.00334	CcSEcCtD
Melatonin—CYP19A1—lymph node—melanoma	0.000279	0.00338	CbGeAlD
Melatonin—Musculoskeletal discomfort—Bleomycin—melanoma	0.000278	0.00333	CcSEcCtD
Melatonin—Chest pain—Carmustine—melanoma	0.000278	0.00333	CcSEcCtD
Melatonin—Anxiety—Carmustine—melanoma	0.000277	0.00332	CcSEcCtD
Melatonin—Paraesthesia—Bleomycin—melanoma	0.000274	0.00329	CcSEcCtD
Melatonin—Weight increased—Docetaxel—melanoma	0.000274	0.00328	CcSEcCtD
Melatonin—Hypertension—Temozolomide—melanoma	0.000273	0.00326	CcSEcCtD
Melatonin—Arthralgia—Temozolomide—melanoma	0.000269	0.00322	CcSEcCtD
Melatonin—Infestation—Docetaxel—melanoma	0.000269	0.00322	CcSEcCtD
Melatonin—Infestation NOS—Docetaxel—melanoma	0.000269	0.00322	CcSEcCtD
Melatonin—Anxiety—Temozolomide—melanoma	0.000268	0.00321	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000267	0.0032	CcSEcCtD
Melatonin—Infection—Carmustine—melanoma	0.000265	0.00317	CcSEcCtD
Melatonin—CYP1A1—head—melanoma	0.000263	0.00319	CbGeAlD
Melatonin—Dry mouth—Temozolomide—melanoma	0.000263	0.00315	CcSEcCtD
Melatonin—Stomatitis—Docetaxel—melanoma	0.000262	0.00314	CcSEcCtD
Melatonin—Pain—Bleomycin—melanoma	0.000261	0.00313	CcSEcCtD
Melatonin—Thrombocytopenia—Carmustine—melanoma	0.000261	0.00313	CcSEcCtD
Melatonin—CYP1B1—lymph node—melanoma	0.000261	0.00316	CbGeAlD
Melatonin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00026	0.00311	CcSEcCtD
Melatonin—Infection—Temozolomide—melanoma	0.000256	0.00307	CcSEcCtD
Melatonin—Hepatobiliary disease—Docetaxel—melanoma	0.000254	0.00304	CcSEcCtD
Melatonin—Nervous system disorder—Temozolomide—melanoma	0.000253	0.00303	CcSEcCtD
Melatonin—Thrombocytopenia—Temozolomide—melanoma	0.000252	0.00302	CcSEcCtD
Melatonin—Skin disorder—Temozolomide—melanoma	0.00025	0.003	CcSEcCtD
Melatonin—Fatigue—Dactinomycin—melanoma	0.000246	0.00294	CcSEcCtD
Melatonin—Pain—Dactinomycin—melanoma	0.000244	0.00292	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Carmustine—melanoma	0.000243	0.00291	CcSEcCtD
Melatonin—ESR1—lymph node—melanoma	0.000242	0.00294	CbGeAlD
Melatonin—Insomnia—Carmustine—melanoma	0.000241	0.00289	CcSEcCtD
Melatonin—CALM2—lymph node—melanoma	0.000241	0.00292	CbGeAlD
Melatonin—CALM1—lymph node—melanoma	0.00024	0.00291	CbGeAlD
Melatonin—Paraesthesia—Carmustine—melanoma	0.00024	0.00287	CcSEcCtD
Melatonin—Urinary tract disorder—Docetaxel—melanoma	0.000238	0.00285	CcSEcCtD
Melatonin—Somnolence—Carmustine—melanoma	0.000237	0.00284	CcSEcCtD
Melatonin—Connective tissue disorder—Docetaxel—melanoma	0.000237	0.00284	CcSEcCtD
Melatonin—Urethral disorder—Docetaxel—melanoma	0.000237	0.00283	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Temozolomide—melanoma	0.000235	0.00281	CcSEcCtD
Melatonin—Insomnia—Temozolomide—melanoma	0.000233	0.00279	CcSEcCtD
Melatonin—Gastrointestinal pain—Dactinomycin—melanoma	0.000233	0.00279	CcSEcCtD
Melatonin—Paraesthesia—Temozolomide—melanoma	0.000231	0.00277	CcSEcCtD
Melatonin—Gastrointestinal disorder—Carmustine—melanoma	0.00023	0.00276	CcSEcCtD
Melatonin—Somnolence—Temozolomide—melanoma	0.000229	0.00274	CcSEcCtD
Melatonin—Pain—Carmustine—melanoma	0.000228	0.00273	CcSEcCtD
Melatonin—Dyspepsia—Temozolomide—melanoma	0.000227	0.00272	CcSEcCtD
Melatonin—Eye disorder—Docetaxel—melanoma	0.000225	0.0027	CcSEcCtD
Melatonin—Abdominal pain—Dactinomycin—melanoma	0.000225	0.0027	CcSEcCtD
Melatonin—Hypersensitivity—Bleomycin—melanoma	0.000225	0.0027	CcSEcCtD
Melatonin—Cardiac disorder—Docetaxel—melanoma	0.000224	0.00268	CcSEcCtD
Melatonin—Gastrointestinal disorder—Temozolomide—melanoma	0.000223	0.00266	CcSEcCtD
Melatonin—Fatigue—Temozolomide—melanoma	0.000222	0.00266	CcSEcCtD
Melatonin—Pain—Temozolomide—melanoma	0.00022	0.00264	CcSEcCtD
Melatonin—Asthenia—Bleomycin—melanoma	0.000219	0.00262	CcSEcCtD
Melatonin—Angiopathy—Docetaxel—melanoma	0.000219	0.00262	CcSEcCtD
Melatonin—Gastrointestinal pain—Carmustine—melanoma	0.000218	0.00261	CcSEcCtD
Melatonin—Immune system disorder—Docetaxel—melanoma	0.000218	0.00261	CcSEcCtD
Melatonin—Pruritus—Bleomycin—melanoma	0.000216	0.00259	CcSEcCtD
Melatonin—Mental disorder—Docetaxel—melanoma	0.000211	0.00253	CcSEcCtD
Melatonin—Abdominal pain—Carmustine—melanoma	0.000211	0.00252	CcSEcCtD
Melatonin—Gastrointestinal pain—Temozolomide—melanoma	0.000211	0.00252	CcSEcCtD
Melatonin—Malnutrition—Docetaxel—melanoma	0.00021	0.00251	CcSEcCtD
Melatonin—Erythema—Docetaxel—melanoma	0.00021	0.00251	CcSEcCtD
Melatonin—Hypersensitivity—Dactinomycin—melanoma	0.00021	0.00251	CcSEcCtD
Melatonin—Asthenia—Dactinomycin—melanoma	0.000204	0.00245	CcSEcCtD
Melatonin—Abdominal pain—Temozolomide—melanoma	0.000204	0.00244	CcSEcCtD
Melatonin—Back pain—Docetaxel—melanoma	0.000203	0.00243	CcSEcCtD
Melatonin—Muscle spasms—Docetaxel—melanoma	0.000202	0.00242	CcSEcCtD
Melatonin—Hypersensitivity—Carmustine—melanoma	0.000197	0.00235	CcSEcCtD
Melatonin—Vomiting—Bleomycin—melanoma	0.000194	0.00233	CcSEcCtD
Melatonin—Rash—Bleomycin—melanoma	0.000193	0.00231	CcSEcCtD
Melatonin—Dermatitis—Bleomycin—melanoma	0.000193	0.0023	CcSEcCtD
Melatonin—Asthenia—Carmustine—melanoma	0.000191	0.00229	CcSEcCtD
Melatonin—Hypersensitivity—Temozolomide—melanoma	0.00019	0.00227	CcSEcCtD
Melatonin—Syncope—Docetaxel—melanoma	0.000188	0.00226	CcSEcCtD
Melatonin—Leukopenia—Docetaxel—melanoma	0.000188	0.00225	CcSEcCtD
Melatonin—Palpitations—Docetaxel—melanoma	0.000186	0.00222	CcSEcCtD
Melatonin—Asthenia—Temozolomide—melanoma	0.000185	0.00221	CcSEcCtD
Melatonin—Loss of consciousness—Docetaxel—melanoma	0.000185	0.00221	CcSEcCtD
Melatonin—CYP1A1—lymph node—melanoma	0.000184	0.00223	CbGeAlD
Melatonin—Pruritus—Temozolomide—melanoma	0.000182	0.00218	CcSEcCtD
Melatonin—Nausea—Bleomycin—melanoma	0.000182	0.00217	CcSEcCtD
Melatonin—Hypertension—Docetaxel—melanoma	0.000181	0.00217	CcSEcCtD
Melatonin—Vomiting—Dactinomycin—melanoma	0.000181	0.00217	CcSEcCtD
Melatonin—Rash—Dactinomycin—melanoma	0.00018	0.00215	CcSEcCtD
Melatonin—Chest pain—Docetaxel—melanoma	0.000179	0.00214	CcSEcCtD
Melatonin—Arthralgia—Docetaxel—melanoma	0.000179	0.00214	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000178	0.00213	CcSEcCtD
Melatonin—Dizziness—Carmustine—melanoma	0.000176	0.00211	CcSEcCtD
Melatonin—Dry mouth—Docetaxel—melanoma	0.000175	0.00209	CcSEcCtD
Melatonin—Dizziness—Temozolomide—melanoma	0.00017	0.00204	CcSEcCtD
Melatonin—Infection—Docetaxel—melanoma	0.00017	0.00204	CcSEcCtD
Melatonin—Vomiting—Carmustine—melanoma	0.00017	0.00203	CcSEcCtD
Melatonin—Nausea—Dactinomycin—melanoma	0.000169	0.00203	CcSEcCtD
Melatonin—Shock—Docetaxel—melanoma	0.000169	0.00202	CcSEcCtD
Melatonin—Rash—Carmustine—melanoma	0.000168	0.00201	CcSEcCtD
Melatonin—Nervous system disorder—Docetaxel—melanoma	0.000168	0.00201	CcSEcCtD
Melatonin—Dermatitis—Carmustine—melanoma	0.000168	0.00201	CcSEcCtD
Melatonin—Thrombocytopenia—Docetaxel—melanoma	0.000168	0.00201	CcSEcCtD
Melatonin—Headache—Carmustine—melanoma	0.000167	0.002	CcSEcCtD
Melatonin—Skin disorder—Docetaxel—melanoma	0.000167	0.00199	CcSEcCtD
Melatonin—Vomiting—Temozolomide—melanoma	0.000164	0.00196	CcSEcCtD
Melatonin—Rash—Temozolomide—melanoma	0.000163	0.00195	CcSEcCtD
Melatonin—Dermatitis—Temozolomide—melanoma	0.000162	0.00194	CcSEcCtD
Melatonin—Headache—Temozolomide—melanoma	0.000161	0.00193	CcSEcCtD
Melatonin—Nausea—Carmustine—melanoma	0.000158	0.0019	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000156	0.00187	CcSEcCtD
Melatonin—Insomnia—Docetaxel—melanoma	0.000155	0.00186	CcSEcCtD
Melatonin—Paraesthesia—Docetaxel—melanoma	0.000154	0.00184	CcSEcCtD
Melatonin—Nausea—Temozolomide—melanoma	0.000153	0.00183	CcSEcCtD
Melatonin—Somnolence—Docetaxel—melanoma	0.000152	0.00182	CcSEcCtD
Melatonin—Dyspepsia—Docetaxel—melanoma	0.000151	0.00181	CcSEcCtD
Melatonin—Gastrointestinal disorder—Docetaxel—melanoma	0.000148	0.00177	CcSEcCtD
Melatonin—Fatigue—Docetaxel—melanoma	0.000148	0.00177	CcSEcCtD
Melatonin—Pain—Docetaxel—melanoma	0.000147	0.00175	CcSEcCtD
Melatonin—Gastrointestinal pain—Docetaxel—melanoma	0.00014	0.00168	CcSEcCtD
Melatonin—Abdominal pain—Docetaxel—melanoma	0.000136	0.00162	CcSEcCtD
Melatonin—Hypersensitivity—Docetaxel—melanoma	0.000126	0.00151	CcSEcCtD
Melatonin—Asthenia—Docetaxel—melanoma	0.000123	0.00147	CcSEcCtD
Melatonin—Pruritus—Docetaxel—melanoma	0.000121	0.00145	CcSEcCtD
Melatonin—Dizziness—Docetaxel—melanoma	0.000113	0.00136	CcSEcCtD
Melatonin—Vomiting—Docetaxel—melanoma	0.000109	0.0013	CcSEcCtD
Melatonin—Rash—Docetaxel—melanoma	0.000108	0.00129	CcSEcCtD
Melatonin—Dermatitis—Docetaxel—melanoma	0.000108	0.00129	CcSEcCtD
Melatonin—Headache—Docetaxel—melanoma	0.000107	0.00129	CcSEcCtD
Melatonin—Nausea—Docetaxel—melanoma	0.000102	0.00122	CcSEcCtD
Melatonin—Nabumetone—PTGS2—melanoma	9.52e-05	0.675	CrCbGaD
Melatonin—Sumatriptan—ABCB1—melanoma	4.59e-05	0.325	CrCbGaD
Melatonin—CALM2—Signaling by GPCR—MAPK3—melanoma	2.13e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—MAPK3—melanoma	2.13e-06	1.07e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PRKCA—melanoma	2.13e-06	1.07e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—CDKN1A—melanoma	2.11e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—CDKN1A—melanoma	2.11e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CB—melanoma	2.11e-06	1.06e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ERCC2—melanoma	2.11e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—STAT3—melanoma	2.11e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IGF1—melanoma	2.11e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTEN—melanoma	2.11e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTEN—melanoma	2.11e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NRAS—melanoma	2.1e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—MAPK1—melanoma	2.1e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—melanoma	2.1e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—BRAF—melanoma	2.09e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—BRAF—melanoma	2.09e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—melanoma	2.09e-06	1.05e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PPARG—melanoma	2.06e-06	1.04e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PIK3CA—melanoma	2.06e-06	1.03e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.04e-06	1.03e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CB—melanoma	2.04e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CB—melanoma	2.04e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—STAT3—melanoma	2.04e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—STAT3—melanoma	2.04e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF1—melanoma	2.04e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF1—melanoma	2.04e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAP2K1—melanoma	2.04e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRAS—melanoma	2.03e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRAS—melanoma	2.03e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—MAPK1—melanoma	2.03e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—MAPK1—melanoma	2.03e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—melanoma	2.03e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—melanoma	2.03e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CD—melanoma	2.02e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—melanoma	2.02e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—melanoma	2.02e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK3—melanoma	2.01e-06	1.01e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CB—melanoma	2e-06	1e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—melanoma	1.98e-06	9.95e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PIK3CA—melanoma	1.98e-06	9.95e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—melanoma	1.98e-06	9.94e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—melanoma	1.97e-06	9.9e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAP2K1—melanoma	1.97e-06	9.89e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAP2K1—melanoma	1.97e-06	9.89e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CD—melanoma	1.96e-06	9.83e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CD—melanoma	1.96e-06	9.83e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STAT3—melanoma	1.95e-06	9.8e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CG—melanoma	1.95e-06	9.78e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK3—melanoma	1.95e-06	9.78e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK3—melanoma	1.95e-06	9.78e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRAS—melanoma	1.95e-06	9.78e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—STAT3—melanoma	1.95e-06	9.77e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—NRAS—melanoma	1.94e-06	9.75e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FGF2—melanoma	1.94e-06	9.73e-06	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—melanoma	1.94e-06	9.71e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—MAPK1—melanoma	1.92e-06	9.62e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—melanoma	1.92e-06	9.62e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—melanoma	1.92e-06	9.62e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—melanoma	1.92e-06	9.62e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—STAT3—melanoma	1.88e-06	9.45e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—STAT3—melanoma	1.88e-06	9.45e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPARG—melanoma	1.88e-06	9.44e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CD—melanoma	1.88e-06	9.43e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—NRAS—melanoma	1.88e-06	9.43e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—NRAS—melanoma	1.88e-06	9.43e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FGF2—melanoma	1.87e-06	9.41e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FGF2—melanoma	1.87e-06	9.41e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK3—melanoma	1.87e-06	9.36e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK3—melanoma	1.86e-06	9.33e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ALB—melanoma	1.85e-06	9.31e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—MAPK1—melanoma	1.85e-06	9.31e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—MAPK1—melanoma	1.85e-06	9.31e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—melanoma	1.85e-06	9.3e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—melanoma	1.85e-06	9.3e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTEN—melanoma	1.82e-06	9.15e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PIK3CA—melanoma	1.82e-06	9.14e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MYC—melanoma	1.81e-06	9.11e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MDM2—melanoma	1.81e-06	9.1e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—melanoma	1.81e-06	9.09e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MYC—melanoma	1.81e-06	9.08e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK3—melanoma	1.8e-06	9.03e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK3—melanoma	1.8e-06	9.03e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB2—melanoma	1.79e-06	8.97e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MAPK1—melanoma	1.77e-06	8.91e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—melanoma	1.77e-06	8.91e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—MAPK1—melanoma	1.77e-06	8.88e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—melanoma	1.77e-06	8.88e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CB—melanoma	1.76e-06	8.85e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTEN—melanoma	1.76e-06	8.85e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTEN—melanoma	1.76e-06	8.85e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PIK3CA—melanoma	1.76e-06	8.84e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PIK3CA—melanoma	1.76e-06	8.84e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MDM2—melanoma	1.75e-06	8.8e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MDM2—melanoma	1.75e-06	8.8e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—melanoma	1.75e-06	8.79e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—melanoma	1.75e-06	8.79e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MYC—melanoma	1.75e-06	8.78e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MYC—melanoma	1.75e-06	8.78e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.75e-06	8.77e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTEN—melanoma	1.73e-06	8.68e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB2—melanoma	1.73e-06	8.68e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB2—melanoma	1.73e-06	8.68e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CD—melanoma	1.71e-06	8.6e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—MAPK1—melanoma	1.71e-06	8.59e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—MAPK1—melanoma	1.71e-06	8.59e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—melanoma	1.71e-06	8.59e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—melanoma	1.71e-06	8.59e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CB—melanoma	1.71e-06	8.56e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CB—melanoma	1.71e-06	8.56e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CXCL8—melanoma	1.69e-06	8.51e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ALB—melanoma	1.69e-06	8.49e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—melanoma	1.68e-06	8.45e-06	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—melanoma	1.68e-06	8.44e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—melanoma	1.68e-06	8.41e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—melanoma	1.67e-06	8.39e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CG—melanoma	1.67e-06	8.36e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—PIK3CA—melanoma	1.66e-06	8.35e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1B—melanoma	1.66e-06	8.31e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CXCL8—melanoma	1.64e-06	8.23e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CXCL8—melanoma	1.64e-06	8.23e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CB—melanoma	1.64e-06	8.22e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—melanoma	1.63e-06	8.18e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—melanoma	1.63e-06	8.18e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—melanoma	1.62e-06	8.15e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—melanoma	1.62e-06	8.14e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL2—melanoma	1.62e-06	8.13e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—melanoma	1.62e-06	8.12e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—melanoma	1.62e-06	8.12e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—melanoma	1.62e-06	8.12e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—melanoma	1.61e-06	8.09e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—PIK3CA—melanoma	1.61e-06	8.08e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—PIK3CA—melanoma	1.61e-06	8.08e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARG—melanoma	1.61e-06	8.07e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1B—melanoma	1.6e-06	8.04e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1B—melanoma	1.6e-06	8.04e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCND1—melanoma	1.58e-06	7.93e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—melanoma	1.57e-06	7.88e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—melanoma	1.57e-06	7.88e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL2—melanoma	1.57e-06	7.87e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL2—melanoma	1.57e-06	7.87e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CTNNB1—melanoma	1.56e-06	7.85e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—melanoma	1.56e-06	7.83e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—melanoma	1.56e-06	7.83e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3CA—melanoma	1.54e-06	7.73e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—melanoma	1.54e-06	7.72e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3CA—melanoma	1.54e-06	7.71e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—melanoma	1.53e-06	7.7e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CDKN1A—melanoma	1.53e-06	7.67e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCND1—melanoma	1.53e-06	7.67e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCND1—melanoma	1.53e-06	7.67e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTEN—melanoma	1.52e-06	7.65e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NFKB1—melanoma	1.52e-06	7.61e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CTNNB1—melanoma	1.51e-06	7.59e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CTNNB1—melanoma	1.51e-06	7.59e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CB—melanoma	1.49e-06	7.5e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—melanoma	1.49e-06	7.48e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—melanoma	1.49e-06	7.47e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—melanoma	1.49e-06	7.47e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—melanoma	1.49e-06	7.46e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3CA—melanoma	1.49e-06	7.46e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3CA—melanoma	1.49e-06	7.46e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—melanoma	1.48e-06	7.44e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—melanoma	1.48e-06	7.44e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—melanoma	1.48e-06	7.43e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CDKN1A—melanoma	1.48e-06	7.42e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CDKN1A—melanoma	1.48e-06	7.42e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTEN—melanoma	1.47e-06	7.4e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTEN—melanoma	1.47e-06	7.4e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—melanoma	1.47e-06	7.39e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NFKB1—melanoma	1.47e-06	7.37e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NFKB1—melanoma	1.47e-06	7.37e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CD—melanoma	1.46e-06	7.35e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ALB—melanoma	1.45e-06	7.26e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—melanoma	1.44e-06	7.22e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—melanoma	1.44e-06	7.22e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—melanoma	1.42e-06	7.15e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—melanoma	1.42e-06	7.15e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—melanoma	1.42e-06	7.15e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—melanoma	1.42e-06	7.13e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTEN—melanoma	1.42e-06	7.1e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—melanoma	1.38e-06	6.91e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—melanoma	1.37e-06	6.9e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—melanoma	1.37e-06	6.9e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—melanoma	1.36e-06	6.85e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STAT3—melanoma	1.36e-06	6.84e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRAS—melanoma	1.36e-06	6.83e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—melanoma	1.36e-06	6.82e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—melanoma	1.36e-06	6.82e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—melanoma	1.33e-06	6.68e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—melanoma	1.33e-06	6.68e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STAT3—melanoma	1.32e-06	6.62e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STAT3—melanoma	1.32e-06	6.62e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRAS—melanoma	1.32e-06	6.6e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRAS—melanoma	1.32e-06	6.6e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—melanoma	1.32e-06	6.6e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—melanoma	1.32e-06	6.6e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—melanoma	1.31e-06	6.6e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—melanoma	1.31e-06	6.6e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK3—melanoma	1.3e-06	6.54e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTEN—melanoma	1.29e-06	6.48e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3CA—melanoma	1.29e-06	6.45e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CB—melanoma	1.28e-06	6.41e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MYC—melanoma	1.27e-06	6.36e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—melanoma	1.26e-06	6.35e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK3—melanoma	1.26e-06	6.32e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK3—melanoma	1.26e-06	6.32e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—melanoma	1.26e-06	6.32e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—melanoma	1.25e-06	6.3e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3CA—melanoma	1.24e-06	6.24e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3CA—melanoma	1.24e-06	6.24e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MAPK1—melanoma	1.24e-06	6.22e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—melanoma	1.24e-06	6.22e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MYC—melanoma	1.23e-06	6.15e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MYC—melanoma	1.23e-06	6.15e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3CA—melanoma	1.22e-06	6.12e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—melanoma	1.21e-06	6.09e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—melanoma	1.21e-06	6.09e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MAPK1—melanoma	1.2e-06	6.02e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MAPK1—melanoma	1.2e-06	6.02e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—melanoma	1.2e-06	6.02e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—melanoma	1.2e-06	6.02e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—melanoma	1.17e-06	5.87e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—melanoma	1.13e-06	5.68e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—melanoma	1.13e-06	5.68e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTEN—melanoma	1.1e-06	5.54e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3CA—melanoma	1.08e-06	5.4e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—melanoma	1.05e-06	5.27e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—melanoma	1.04e-06	5.22e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3CA—melanoma	1.04e-06	5.22e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3CA—melanoma	1.04e-06	5.22e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—melanoma	1.02e-06	5.1e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—melanoma	1.02e-06	5.1e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—melanoma	1.01e-06	5.05e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—melanoma	1.01e-06	5.05e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3CA—melanoma	9.98e-07	5.01e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—melanoma	9.97e-07	5e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—melanoma	9.95e-07	4.99e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—melanoma	9.62e-07	4.83e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—melanoma	9.62e-07	4.83e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—melanoma	9.52e-07	4.78e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—melanoma	9.21e-07	4.62e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—melanoma	9.21e-07	4.62e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3CA—melanoma	9.1e-07	4.57e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—melanoma	8.78e-07	4.41e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—melanoma	8.5e-07	4.27e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—melanoma	8.5e-07	4.27e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—melanoma	8.16e-07	4.09e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3CA—melanoma	7.78e-07	3.91e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—melanoma	7.44e-07	3.73e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—melanoma	6.36e-07	3.19e-06	CbGpPWpGaD
